CClinicalTrials.gg
CompletedNCT06906159CriProBUpdated Apr 2, 2025

Cricket Protein Bioavailability in Younger, Middle-Aged and Older Adults

An interventional study of Cricket protein and Whey protein in Cricket Protein and Whey Protein, sponsored by University of Surrey. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-02.

Sponsored by University of Surrey · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Mar 2024, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A global shift towards sustainable food sources is now emerging, largely due to the immense environmental pressure that comes from producing animal foods, particularly beef. Insects present a novel source of sustainable dietary protein due to their high protein content. This is particularly relevant for older adults, as protein becomes increasingly more important in later life. It helps to maintain muscle as we age, which is crucial for reducing frailty, falls and early mortality. We want to find out more about the digestion and absorption of insect protein in older people to see if it could be a beneficial source of protein to help maintain muscle. We are interested in the use of insect-based solid foods, especially the use of flour made from grounded whole crickets. We want to explore the digestibility of cricket protein compared to a commonly used animal alternative (whey protein) to find out if it can be efficiently absorbed and utilised within humans.

Read the detailed description

Participants are asked to fast overnight and come in the following day for one of two visits where they are given a standardised breakfast muffin containing either cricket protein or whey protein (250-300 kcal; approx. 12% fat, 45% carbohydrates including 10% sugars, 35% protein, 0.4% salt and 6% fibre) after which they breathe into a test tube in 15-30 minute intervals for 4 hours. In addition to this, we collect a blood sample (10ml) every 15 minutes for the first hour and then every 30 minutes for the next 3 hours (110ml of blood in total per visit) so we can determine changes in blood amino acids, glucose and fat concentrations after eating the muffin. In total we only collect a small amount of blood. This method of blood collection is the same method used for a traditional blood test but to avoid repeated needle insertions we use a cannula which remains in the participant's arm for the duration of the visit so that only a single needle insertion is necessary.

The muffin contains a small amount of a natural fat called octanoic acid. The octanoic acid is enriched with carbon-13. This is a natural variant of carbon and is safe to use, even in babies and pregnant women. At the end of each test visit we ask participants to fill out a short questionnaire to ask about the taste of the muffins. Participants are required to repeat this whole process for a second visit in which they consume the other muffin.

The muffins are identical between the two test visits with the exception that one muffin is made with a milk-based protein (whey) whereas the other test muffin is made with an insect protein (cricket). The test muffins are similar in size, shape, and taste. Participants are randomised to a muffin condition in a crossover design. Participants are blinded to the muffin condition and only one member of the research team knows which muffin participants receive on which test visit but they are not present during the test visits. The researchers conducting the test visits do not know which muffin is being consumed by participants.

Participants are required to attend for 2 test visits each lasting approximately 5 hours. This takes place in the Clinical Investigation Unit (CIU) at the University of Surrey. On the day before each of the test visits participants are asked to arrive fasted for 12 hours overnight, refrain from strenuous exercise, alcohol, caffeine and food containing corn, broccoli, sugarcane, and tropical fruits (because of the type of natural carbon-13 they contain) the day before their visits.

02

Conditions studied

  • Cricket Protein
  • Whey Protein
03

In context

Lead sponsor

University of Surrey is the lead sponsor of 90 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy adult males and females in general good health, aged between 18 - 35 years, 40 - 55 years or over 65 years
  • BMI between 18.5 and 35 kg/m2
  • Stable weight for at least 3 months
  • Volunteers must be able and willing to give informed written consent
  • Volunteers must be able to eat egg
  • Volunteers must be willing to provide blood samples

Exclusion criteria

Exclusion Criteria:

  • Current or previous gastrointestinal conditions (e.g. Crohn's disease, Coeliac disease, Irritable Bowel Syndrome) - assessed via a health questionnaire
  • Those with diabetes or other metabolic conditions - assessed via a health questionnaire
  • Those taking food supplements which may impact digestion (e.g., digestive enzymes, probiotics, fibre supplements)
  • Those smoking, using nicotine products (e.g., e-cigarettes, patches) or not abstained from these activities for more than 6 months - assessed via a health questionnaire
  • Pregnant or lactating
  • Volunteers with a high daily caffeine intake > 300 mg/day (more than 5 cups of standard coffee per day)
  • Drug or alcohol abuse in the last 2 years
  • Those who are currently taking part in a clinical trial or another research study or have taken part within the last 3 months
  • Those with food allergies, dietary intolerance or Coeliac disease - assessed via a health questionnaire
  • Those following weight loss diets
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    Cricket muffin

    Muffin made with cricket-derived protein powder

    Dietary Supplement: Cricket protein

  • Active comparator
    Whey muffin

    Muffin made with whey protein powder

    Dietary Supplement: Whey protein

Interventions

  • Dietary supplementCricket protein

    Muffins made with cricket-derived protein from house crickets (Acheta domesticus )

  • Dietary supplementWhey protein

    Muffins made with whey protein

06

What researchers measure

Primary outcomes

  1. Gastric emptying

    Exhaled breath is used to assess the rate of gastric emptying of the protein muffins

    Time frame: 4 hour post-prandial period

  2. Plasma amino acids

    Blood samples are used to assess the plasma amino acid response to consuming the protein muffins

    Time frame: 4 hour post-prandial period

Secondary outcomes

  1. Metabolic markers

    Blood samples are also used to assess post-prandial glucose, triglycerides and cholesterol

    Time frame: 4 hour post-prandial period

07

Study locations

1 site
  • University of Surrey
    Guildford, Surrey GU2 7XH, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06906159
Lead sponsor
University of Surrey
Collaborators
HOP
Responsible party
Sponsor
First posted
Apr 2, 2025
Start date
Mar 11, 2024
Primary completion
Mar 10, 2025
Completion
Mar 10, 2025
Last update
Apr 2, 2025

Study contacts

James Rutherford, MSc
study director · University of Surrey

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion